José María Aguado

55PUBLICATIONS
157CO-AUTHORS
Food properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 28, 2026
Solid Organ Transplant Recipients With Clostridioides difficile Infection Had Lower Fecal Calprotectin and Lactoferrin Levels Compared to Immunocompetent Patients: Implications for Biomarker Interpretation.

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Feb 20, 2026
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice.

Jorge Boán, Eduardo Aparicio-Minguijón, Mario Fernández-Ruiz

|Dec 24, 2025
The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation.

Jorge Boán, Mario Fernández-Ruiz, Eduardo Aparicio-Minguijón

|Oct 27, 2025
Chronic lung infection by Achromobacter xylosoxidans in a patient with cystic fibrosis successfully treated with cefiderocol as a pre and post-lung transplant regimen.

Susana Ramos-Oliveira, Rodrigo Alonso-Moralejo, Virginia Pérez

|Sep 16, 2025
Challenges and controversies of urinary tract infection treatment in kidney transplant recipients.

Mario Fernández-Ruiz, José María Aguado, Francisco López-Medrano

Pageof 10

Frequent Collaborators

36 joint publications

Mario Fernández-Ruiz

31 joint publications

Francisco López-Medrano

22 joint publications

Rocío Laguna-Goya

16 joint publications

Isabel Rodríguez-Goncer